The Discounted Cash Flow (DCF) valuation of Corcept Therapeutics Inc (CORT) is 37.44 USD. With the latest stock price at 34.70 USD, the upside of Corcept Therapeutics Inc based on DCF is 7.9%.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 7.8% | 7.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 25.37 - 78.92 | 37.44 |
| Upside | -26.9% - 127.4% | 7.9% |